12 Skin Sensitivity Changes That Accompany Nerve and Autoimmune Disorders

6. Burning Skin Syndrome - Persistent Inflammatory Sensations

Burning skin syndrome encompasses a constellation of symptoms characterized by persistent, intense burning sensations affecting the skin surface, often accompanied by redness, warmth, and hypersensitivity to touch. This condition commonly occurs in patients with small fiber neuropathy, where damage to unmyelinated C-fibers and thinly myelinated A-delta fibers disrupts normal pain and temperature processing. Autoimmune conditions such as systemic lupus erythematosus, Sjögren's syndrome, and celiac disease frequently present with small fiber involvement, leading to burning pain that typically affects the distal extremities but can occur anywhere on the body. The pathophysiology involves dysfunction of nociceptive nerve endings, which become spontaneously active and hyperresponsive to normally innocuous stimuli. Inflammatory mediators released during autoimmune processes, including tumor necrosis factor-alpha, interleukins, and complement proteins, directly sensitize these nerve endings and perpetuate the burning sensation. Patients often describe the pain as constant and severe, likening it to having their skin on fire or being repeatedly exposed to intense heat. The burning sensation may be accompanied by other symptoms such as tingling, electric shock-like pains, or crawling sensations, collectively known as dysesthesias. Sleep disturbances are common, as the burning pain often intensifies at night when other sensory inputs are reduced. The condition can significantly impact quality of life, leading to depression, anxiety, and social withdrawal. Diagnosis often requires specialized testing such as skin biopsy to assess intraepidermal nerve fiber density or quantitative sensory testing to evaluate small fiber function. Treatment approaches include topical agents like capsaicin or lidocaine, systemic medications such as gabapentinoids or tricyclic antidepressants, and addressing underlying autoimmune inflammation through immunosuppressive therapy.